Internal Medicine, Infectious Disease · Honolulu, HI
NPI
1457436941
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
1010 S King St, Suite 111
Honolulu, HI, 96814
Phone (808) 597-8765
Groups this clinician bills Medicare through
Medicare paid, 2024
$251K
3,591 services
Medicare patients, 2024
509
Average age 78
Drug cost, 2024
$2.5M
3,444 prescriptions
Company payments, 2025
$3,263
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian C Pien was code 99232 (hospital e&m - subsequent), 1,850 times for 297 patients. In total Brian C Pien billed 3,591 services in 14 codes, and Medicare paid $251K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,850 | 297 | $61.56 | $114K |
| 99214 Office E&M - Established | Office | 784 | 291 | $96.95 | $76K |
| 99231 Hospital E&M - Subsequent | Facility | 543 | 171 | $38.50 | $21K |
| 99222 Hospital E&M - Initial | Facility | 303 | 275 | $97.44 | $30K |
| 99204 Office E&M - New | Office | 68 | 68 | $124.23 | $8,448 |
By year: 2022 $257K for 3,971 services; 2023 $247K for 3,504 services; 2024 $251K for 3,591 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brian C Pien prescribed most often to Medicare patients was Meropenem, with 207 prescriptions and refills. In total Brian C Pien wrote 3,444 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Meropenem Generic | 207 | 207 | 25 | $45K |
| Doxycycline Hyclate Generic | 154 | 237 | 94 | $5,007 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 135 | 189 | 81 | $7,112 |
| Ciprofloxacin Hcl Generic | 121 | 142 | 81 | $2,332 |
| Atorvastatin Calcium Generic | 102 | 305 | 36 | $2,650 |
| Levofloxacin Generic | 88 | 113 | 57 | $1,214 |
| Ceftriaxone Ceftriaxone Sodium | 85 | 85 | 18 | $20K |
| Cefuroxime Cefuroxime Axetil | 84 | 103 | 63 | $3,445 |
| Vancomycin Hcl Generic | 78 | 88 | 18 | $11K |
| Ceftazidime Generic | 78 | 78 | 14 | $13K |
| Amlodipine Besylate Generic | 77 | 228 | 23 | $800 |
| Fosfomycin Tromethamine Generic | 76 | 76 | 25 | $12K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 73 | 117 | 35 | $1,555 |
| Amoxicillin Generic | 60 | 118 | 28 | $417 |
| Methenamine Hippurate Generic | 59 | 173 | 25 | $5,099 |
Brand drugs: 455 claims; generic drugs: 2,968 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian C Pien $3,263 ($3,263 in general payments such as food, travel and fees) from 14 companies. The largest payer was Gilead Sciences, Inc. with $1,116.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 40 | $1,116 |
| Abbvie Inc. ABBV | 38 | $705 |
| Insmed, Inc. INSM | 31 | $562 |
| Merck Sharp & Dohme LLC MRK | 10 | $291 |
| ViiV Healthcare Company GSK | 9 | $210 |
| Shionogi Inc 4507.T | 4 | $119 |
| Ferring Pharmaceuticals Inc. | 2 | $60.15 |
| Aimmune Therapeutics, Inc. | 2 | $56.74 |
| Cumberland Pharmaceuticals, Inc. CPIX | 2 | $33.45 |
| Esperion Therapeutics, Inc. ESPR | 1 | $24.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.